Context Therapeutics Inc. — Director's Dealing 2021

Dec 17, 2021

SEC Form 3/A — Form 3/A

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2021-10-19

Reporting Person: Rencher William F. (Head of CMC and Regulatory)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$20.52	2028-08-27	Common Stock (416.0)		Direct

Footnotes

F1: Fully vested